Cargando…

Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms

Dysbiosis of the gut microbiome has been correlated with irritable bowel syndrome (IBS). Fecal microbiota transplantation (FMT) is being explored as a therapeutic option. Little is known of the mechanisms of engraftment of microbes following FMT and whether the engraftment of certain microbes correl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Browne, Patrick Denis, Cold, Frederik, Petersen, Andreas Munk, Halkjær, Sofie Ingdam, Christensen, Alice Højer, Günther, Stig, Hestbjerg Hansen, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183560/ https://www.ncbi.nlm.nih.gov/pubmed/34074214 http://dx.doi.org/10.1080/19490976.2021.1927635

Ejemplares similares

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2023)

Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection
por: Chehri, Mahtab, et al.
Publicado: (2018)

Fecal Microbiota Transplantation in the Treatment of Chronic Pouchitis: A Systematic Review
por: Cold, Frederik, et al.
Publicado: (2020)

Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study
por: Cold, Frederik, et al.
Publicado: (2022)

Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy
por: Cold, Frederik, et al.
Publicado: (2021)

Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis
por: Mirsepasi-Lauridsen, Hengameh C., et al.
Publicado: (2016)

Lacticaseibacillus rhamnosus GG Versus Placebo for Eradication of Vancomycin-Resistant Enterococcus faecium in Intestinal Carriers: A Systematic Review and Meta-Analysis
por: Rubin, Ingrid Maria Cecilia, et al.
Publicado: (2023)

The fecal mycobiome in patients with Irritable Bowel Syndrome
por: Das, A., et al.
Publicado: (2021)

THE MOUSE INTESTINAL MICROFLORA WITH EMPHASIS ON THE STRICT ANAEROBES
por: Lee, Adrian, et al.
Publicado: (1971)

Effect of cryopreservation and lyophilization on viability and growth of strict anaerobic human gut microbes
por: Bircher, Lea, et al.
Publicado: (2018)

Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome
por: Goepp, Julius, et al.
Publicado: (2014)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome
por: Ahmed, Iftikhar, et al.
Publicado: (2013)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
por: Choi, You Jin, et al.
Publicado: (2019)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Effects of probiotics (Vivomixx®) in obese pregnant women and their newborn: study protocol for a randomized controlled trial
por: Halkjaer, Sofie Ingdam, et al.
Publicado: (2016)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
por: Wang, Yao, et al.
Publicado: (2019)

Draft Genome Sequence of a Strictly Anaerobic Dichloromethane-Degrading Bacterium
por: Kleindienst, Sara, et al.
Publicado: (2016)

Medium Preparation for the Cultivation of Microorganisms under Strictly Anaerobic/Anoxic Conditions
por: Wagner, Andreas O., et al.
Publicado: (2019)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Genetic and phenotypic diversity of fecal Candida albicans strains in irritable bowel syndrome
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome
por: Wang, Taojun, et al.
Publicado: (2022)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after Fecal Microbiota Transplant in Inflammatory Bowel Disease
por: Zhang, Yanjia Jason, et al.
Publicado: (2023)

Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome
por: von Arnim, Ulrike, et al.
Publicado: (2016)

Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol
por: Wen, Wenting, et al.
Publicado: (2018)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
por: Sundin, Johanna, et al.
Publicado: (2020)

A53 FECAL BIOACTIVE PHOSPHOLIPIDS AS TRIGGERS OF INTESTINAL HYPERSENSITIVITY IN IRRITABLE BOWEL SYNDROME
por: Pujo, J, et al.
Publicado: (2023)

Fecal lactoferrin in discriminating inflammatory bowel disease from Irritable bowel syndrome: a diagnostic meta-analysis
por: Zhou, Xing-lu, et al.
Publicado: (2014)

Draft Genome Sequence of the Strict Anaerobe Clostridium neopropionicum X4 (DSM 3847(T))
por: Beck, Matthias H., et al.
Publicado: (2016)

SUSCEPTIBILITY OF STRICT AND FACULTATIVE ANAEROBES ISOLATED FROM ENDODONTIC INFECTIONS TO METRONIDAZOLE AND β-LACTAMS
por: Gaetti-Jardim, Elerson, et al.
Publicado: (2007)

The Historical Development of Cultivation Techniques for Methanogens and Other Strict Anaerobes and Their Application in Modern Microbiology
por: Hanišáková, Nikola, et al.
Publicado: (2022)

Associations of Fecal Short Chain Fatty Acids With Colonic Transit, Fecal Bile Acid, and Food Intake in Irritable Bowel Syndrome
por: Waseem, Mohammed Rayyan, et al.
Publicado: (2022)

The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study
por: Mazzawi, Tarek, et al.
Publicado: (2022)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
por: Kalantari, Hamid, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1puerjre9s1s2j1jvqderd2l31